Concept

ANVISA Grants Commercial Approval to Concept Medical’s MagicTouch Sirolimus-Coated Balloon for CAD in Brazil

Revolutionary ANVISA Approval Advances Cardiovascular Treatment in Brazil with Concept Medical’s MagicTouch São Paulo (Brazil), September 17:  Concept Medical Group, a global leader in drug-delivery technologies, announced that ANVISA (Agência Nacional de Vigilância Sanitária), Brazil’s Health Surveillance Agency, has granted commercial approval for its flagship MagicTouch, Sirolimus-Coated Balloon (SCB) for CAD treatment. This milestone enables patients […]

Continue Reading
MagicTouch - PNN

MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation

MagicTouch Receives Groundbreaking ANVISA Approval for Coronary Treatment in Brazil São Paulo (Brazil), September 17: The Brazilian health sector has just experienced a turning point with the MagicTouch Brazil Approval from ANVISA, the health surveillance national authority. Concept Medical Group, the drug-delivery technology market leader, has obtained commercial approval for its lead Sirolimus-Coated Balloon (SCB) […]

Continue Reading